Bullish option flow detected in Iovance Biotherapeutics (IOVA) with 13,526 calls trading, 1.3x expected, and implied vol increasing over 11 points to 119.35%. Mar-25 20 calls and Dec-24 9 calls are the most active options, with total volume in those strikes near 7,200 contracts. The Put/Call Ratio is 0.13. Earnings are expected on February 26th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- JMP Securities healthcare analyst holds an analyst/industry conference call
- Iovance Biotherapeutics’ Strong Q3 2024 Performance
- Closing Bell Movers: Toast gains 19% afterhours after earnings beat
- Iovance Biotherapeutics reports Q3 EPS (28c), consensus (30c)
- Unusually active option classes on open November 5th